| TTM
|
6/30/2026
|
6/30/2025
|
6/30/2024
|
6/30/2023
|
|
|---|---|---|---|---|---|
| Total Revenue
|
120,250 | 120,250 | 17,198 | 5,902 | 7,501 |
| Cost of Revenue
|
-16,667 | -16,667 | -5,130 | 0 | 0 |
|
Gross Profit
|
103,583 | 103,583 | 12,068 | 5,902 | 7,501 |
| Selling, General and Administrative Expenses
|
-57,346 | -57,346 | -39,309 | -24,980 | -27,480 |
|
Research and Development Expenses
|
-97,509 | -97,509 | -34,807 | -39,716 | -52,816 |
|
Taxes Other Than Income Taxes
|
0 | 0 | -480 | -37 | 0 |
| Other Income/Expense, Operating
|
22 | 22 | 85 | 2,570 | 3,506 |
|
Operating Income/Expenses
|
-154,833 | -154,833 | -74,511 | -62,126 | -76,790 |
|
Total Operating Profit/Loss
|
-51,250 | -51,250 | -62,443 | -56,224 | -69,289 |
| Total Net Finance Income/Expense
|
-17,960 | -17,960 | -18,998 | -23,009 | -18,613 |
| Net Investment Income
|
1,928 | 1,928 | -5,068 | 779 | -2,368 |
| Irregular Income/Expenses
|
10,395 | 10,395 | -15,303 | -9,693 | 8,169 |
|
Non-Operating Income/Expenses, Total
|
-5,637 | -5,637 | -39,369 | -31,923 | -12,812 |
|
Pretax Income
|
-56,887 | -56,887 | -101,812 | -88,147 | -82,101 |
|
Provision for Income Tax
|
-613 | -613 | -330 | 191 | 212 |
|
Net Income from Continuing Operations
|
-57,500 | -57,500 | -102,142 | -87,956 | -81,889 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-57,500 | -57,500 | -102,142 | -87,956 | -81,889 |
|
Net Income after Non-Controlling/Minority Interests
|
-57,500 | -57,500 | -102,142 | -87,956 | -81,889 |
|
Net Income Available to Common Stockholders
|
-57,500 | -57,500 | -102,142 | -87,956 | -81,889 |
|
Diluted Net Income Available to Common Stockholders
|
-57,500 | -57,500 | -102,142 | -87,956 | -81,889 |
| Basic EPS
|
-0.04 | -0.04 | -0.08 | -0.09 | -0.11 |
| Diluted EPS
|
-0.04 | -0.04 | -0.08 | -0.09 | -0.11 |
|
Basic Weighted Average Shares Outstanding
|
1,294,866.9330 | 1,294,866.9330 | 1,207,793.1320 | 986,702.9190 | 777,719.0910 |
|
Diluted Weighted Average Shares Outstanding
|
1,294,866.9330 | 1,294,866.9330 | 1,207,793.1320 | 986,702.9190 | 777,719.0910 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
-40,929 | -40,929 | -83,613 | -65,138 | -63,488 |
|
EBITDA
|
-34,803 | -34,803 | -79,676 | -65,138 | -63,488 |
|
Normalized EBITDA
|
-46,057 | -46,057 | -59,411 | -56,224 | -69,452 |
|
Normalized Income
|
-65,377.8000 | -65,377.8000 | -87,956.5000 | -79,061.3166 | -87,837.6010 |
|
Total Unusual Items
|
-11,254 | -11,254 | 20,265 | 8,914 | -5,964 |
6/30/2023 - 12/14/2004
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade